We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Gastroenterology

Gastroenterology

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

Mucosal Impedance: A Novel Diagnostic Tool for Refining GERD Phenotyping and Surgical Decision-Making
GastroenterologyEsophageal Mucosal IntegrityGastroesophageal Reflux Disease

Mucosal Impedance: A Novel Diagnostic Tool for Refining GERD Phenotyping and Surgical Decision-Making

By MedXY|Apr 26, 2026

Mucosal impedance (MI) offers a groundbreaking approach to assess esophageal mucosal integrity in GERD, complementing traditional diagnostics and enhancing surgical outcomes.

Combination Therapy with GLP-1 Receptor Agonists and SGLT-2 Inhibitors Reduces Liver and Cardiovascular Risks in MASLD and Type 2 Diabetes
Diabetes & EndocrinologyGLP-1 receptor agonistMASLD

Combination Therapy with GLP-1 Receptor Agonists and SGLT-2 Inhibitors Reduces Liver and Cardiovascular Risks in MASLD and Type 2 Diabetes

By MedXY|Apr 25, 2026

A study reveals that combining GLP-1 receptor agonists with SGLT-2 inhibitors significantly lowers the risk of major adverse liver and cardiovascular outcomes in patients with MASLD and type 2 diabetes compared to monotherapy.

CD16+ γδ T Cells: A Novel Player in HBV Viral Control Through Antibody-Dependent Cytotoxicity
GastroenterologyADCCHBV

CD16+ γδ T Cells: A Novel Player in HBV Viral Control Through Antibody-Dependent Cytotoxicity

By MedXY|Apr 25, 2026

A study reveals CD16+ γδ T cells as key mediators of antibody-dependent cellular cytotoxicity in HBV infection, correlating with reduced viral replication and offering new therapeutic targets.

Clonal Lymphocyte Expansions and JAK-STAT Mutations Drive Refractory Celiac Disease
Gastroenterologyclonal lymphocyte expansionintestinal lymphoma

Clonal Lymphocyte Expansions and JAK-STAT Mutations Drive Refractory Celiac Disease

By MedXY|Apr 25, 2026

This study uncovers clonal lymphocyte expansions and JAK-STAT pathway mutations as key drivers of refractory celiac disease, suggesting a shared pathogenic continuum between RCD1 and RCD2 while cautioning against JAK inhibitor monotherapy d

A New Framework to Refine Hepatocellular Cancer Surveillance with Risk Stratification Models
Gastroenterologycirrhosishepatocellular carcinoma

A New Framework to Refine Hepatocellular Cancer Surveillance with Risk Stratification Models

By MedXY|Apr 23, 2026

The Translational Liver Cancer Consortium proposes a structured framework for developing and validating risk models to optimize HCC surveillance, addressing gaps in current clinical guidelines.

Protein Misfolding in the Gut: A Window into Future Neurodegeneration
Gastroenterologybiomarkergastrointestinal biopsy

Protein Misfolding in the Gut: A Window into Future Neurodegeneration

By MedXY|Apr 23, 2026

GI biopsies reveal misfolded proteins years before neurological symptoms appear, offering a new biomarker for early neurodegenerative disease prediction and intervention.

Somatostatin in the Gut: No Diabetes-Specific Patterns Found
Diabetes & Endocrinologyintestinal mucosasomatostatin

Somatostatin in the Gut: No Diabetes-Specific Patterns Found

By MedXY|Apr 22, 2026

New study reveals uniform distribution of somatostatin and its receptors throughout the intestinal tract in both healthy individuals and type 2 diabetes patients, challenging previous assumptions about its role in diabetes pathophysiology.

Unraveling the Gut-Heart Connection: How Leaky Gut Fuels Atrial Fibrillation in Aging
Cardiologyagingatrial fibrillation

Unraveling the Gut-Heart Connection: How Leaky Gut Fuels Atrial Fibrillation in Aging

By MedXY|Apr 22, 2026

Researchers identify JNK2 as a key mediator in gut-heart crosstalk, linking intestinal permeability to atrial fibrillation pathogenesis through inflammatory stress signals, offering new therapeutic targets.

腹腔鏡と開腹手術による小腸閉塞癒着剥離の長期転帰:LASSO無作為化臨床試験
Gastroenterology癒着剥離

腹腔鏡と開腹手術による小腸閉塞癒着剥離の長期転帰:LASSO無作為化臨床試験

By MedXY|Apr 20, 2026

小腸閉塞手術における腹腔鏡アプローチは短期回復が早いが、5年間の追跡調査では再発率、ヘルニア発生率、QOLにおいて開腹手術と同等の結果を示した。術式選択は患者個別の要因に基づくべきである。

OCE-205 Signals a Potential New Direction for Hepatorenal Syndrome-AKI, with Tolerability at the Center
Gastroenterologyacute kidney injuryhepatorenal syndrome

OCE-205 Signals a Potential New Direction for Hepatorenal Syndrome-AKI, with Tolerability at the Center

By MedXY|Apr 20, 2026

In a phase 2 randomized trial, OCE-205 improved HRS-AKI in more patients than placebo and showed no excess ischemic or respiratory toxicity, but the study was underpowered after early termination.

A Blood-Based Extracellular Vesicle RNA Signature May Offer a New Way to Diagnose Chronic Pancreatitis
Gastroenterologybiomarkerchronic pancreatitis

A Blood-Based Extracellular Vesicle RNA Signature May Offer a New Way to Diagnose Chronic Pancreatitis

By MedXY|Apr 20, 2026

A five-RNA extracellular vesicle signature showed strong diagnostic performance for chronic pancreatitis and may also reflect acinar-to-ductal metaplasia and disease-related metabolic features.

Delayed Surgery in Bowel Obstruction: A Hidden Driver of Mortality and Recurrence in France
GastroenterologyAdhesive small bowel obstructionlaparoscopic surgery

Delayed Surgery in Bowel Obstruction: A Hidden Driver of Mortality and Recurrence in France

By MedXY|Apr 14, 2026

A nationwide French study reveals that surgical delay beyond 9 days triples early mortality risk compared to immediate surgery. While non-operative management carries higher long-term recurrence, timely laparoscopic intervention offers the

Perioperative Nivolumab Combined with Irreversible Electroporation Shows Antitumoral Effect in High-Risk BCLC A Hepatocellular Carcinoma: Results from the NIVOLEP Phase 2 Trial
Gastroenterologyablation therapyhepatocellular carcinoma

Perioperative Nivolumab Combined with Irreversible Electroporation Shows Antitumoral Effect in High-Risk BCLC A Hepatocellular Carcinoma: Results from the NIVOLEP Phase 2 Trial

By MedXY|Apr 14, 2026

The NIVOLEP phase 2 trial demonstrates that perioperative nivolumab (neoadjuvant and adjuvant) combined with irreversible electroporation achieves 70.6% one-year local recurrence-free survival in BCLC A HCC patients with high recurrence ris

Portal Tryptophan Depletion Drives Hyper-Reactive Neutrophils in Alcoholic Liver Disease: Insights from a Prospective TIPS Study
Gastroenterologyalcoholic liver diseaseneutrophil activation

Portal Tryptophan Depletion Drives Hyper-Reactive Neutrophils in Alcoholic Liver Disease: Insights from a Prospective TIPS Study

By MedXY|Apr 14, 2026

A prospective study reveals that decreased tryptophan levels in portal circulation induce neutrophil hyperactivation in alcoholic liver disease. In vitro supplementation with tryptophan ameliorated neutrophil activation, identifying the gut

Kissing and Celiac Disease: New Evidence That Simple Precautions Effectively Minimize Gluten Transfer Risk
Gastroenterologyceliac diseaseceliac-discordant couples

Kissing and Celiac Disease: New Evidence That Simple Precautions Effectively Minimize Gluten Transfer Risk

By MedXY|Apr 14, 2026

A prospective study in Gastroenterology examined gluten transfer through kissing in celiac-discordant couples. Researchers found that while low-level gluten is detectable in saliva, the risk of clinically significant transfer is minimal. A

Redefining Gluten Thresholds in Celiac Disease: The Role of Interleukin-2 as a Biomarker for Immune Activation
Clinical Updatesceliac diseaseImmunomonitoring

Redefining Gluten Thresholds in Celiac Disease: The Role of Interleukin-2 as a Biomarker for Immune Activation

By MedXY|Apr 9, 2026

This review synthesizes recent clinical evidence establishing Interleukin-2 as the primary biomarker for acute gluten exposure in celiac disease, revealing that immune activation occurs at doses significantly lower than currently used in fo

New EHR-Based Model PRIME Achieves 0.75 AUC in Predicting Pancreatic Cancer Risk Across 11 Million Patients
Gastroenterologyearly detectionEHR

New EHR-Based Model PRIME Achieves 0.75 AUC in Predicting Pancreatic Cancer Risk Across 11 Million Patients

By MedXY|Apr 6, 2026

Researchers developed PRIME, a parsimonious risk stratification model for pancreatic ductal adenocarcinoma using electronic health record data. Validated across US health systems and the UK Biobank, PRIME retained 19 predictors and achieved

Why Hepatitis E Remains a Silent Threat in Transplant Recipients: Key Insights from Two Decades of Data
GastroenterologyimmunosuppressionLiệu pháp ribavirin

Why Hepatitis E Remains a Silent Threat in Transplant Recipients: Key Insights from Two Decades of Data

By MedXY|Apr 6, 2026

A 20-year retrospective study of 6,452 solid organ transplant patients reveals hepatitis E infection rates of 3.5%, with chronicity rates exceeding 65%. The findings highlight the critical importance of HEV screening and the effectiveness o

The Gut-Liver Axis Unveiled: How Microbiome Signatures Track Disease Progression from Fatty Liver to Cancer
Gastroenterologybiomarkersgut-liver axis

The Gut-Liver Axis Unveiled: How Microbiome Signatures Track Disease Progression from Fatty Liver to Cancer

By MedXY|Apr 5, 2026

A landmark multicohort study of 1,168 individuals reveals that gut microbiome diversity systematically declines across liver disease stages, with specific bacterial markers like Veillonella and functional metabolic shifts predicting disease

The Unfinished Agenda in Helicobacter pylori Treatment: Resistance, Microbiome Effects, and Future Directions
Clinical UpdatesAntimicrobial ResistanceHelicobacter pylori

The Unfinished Agenda in Helicobacter pylori Treatment: Resistance, Microbiome Effects, and Future Directions

By MedXY|Apr 5, 2026

This review synthesizes the evolving landscape of H. pylori management, highlighting the rise of P-CAB-based therapies, the impact of antibiotic resistance on global eradication strategies, and the expanding recognition of extragastric dise

Prev
12 / 25
1…1011121314…25
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities

Browse by specialty

Open language-specific specialty feeds and department pages.

news6629 articlesCardiology1375 articlesClinical Updates1288 articlesOncology1139 articlesDiabetes & Endocrinology842 articlesNeurology820 articlesPublic Health595 articlesGastroenterology572 articles
Hematology-Oncology
487 articles
Pediatrics484 articles
Internal Medicine444 articles